Skip to main content
Log in

Cryptococcosis in AIDS patients: observations concerning CNS involvement

  • Original Investigations
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

The clinical course and response to therapy of seven patients with cryptococcosis and AIDS were reviewed. One patient was still in the primary stage of cryptococcosis in AIDS, i.e. the stage that is characterized by the sole cultural detection of Cryptococcus neoformans in the respiratory tract. The other six patients were in the secondary stage, where C. neoformans can be detected from the cerebrospinal fluid (CSF), blood, urine, faeces and other body sites. The main presenting features (headache, fever, nausea) were due to central nervous system involvement, although meningism and mental changes were rarely present, and CSF changes were very subtle. Treatment with amphotericin B and flucytosine was very effective, there being no more growth of fungi in cultures in most cases. Adverse reactions to the drugs used occurred frequently and consisted mainly of anaemia, hepatosis and fever. Diagnosis in the primary stage of cryptococcosis may improve the prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Andriole VT, Kravetz HM (1962) The use of amphotericin B in man. JAMA 180:269–272

    Google Scholar 

  2. Bahls F, Sumi SM (1986) Cryptococcal meningitis and cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome. J Neurol Neurosurg Psych 49:328–330

    Google Scholar 

  3. Bennett JE (1977) Flucytosine. Ann Intern Med 86:319–322

    Google Scholar 

  4. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Alling DW (1979) A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 301:126–131

    Google Scholar 

  5. Bloomfield N, Gordon MA, Elmendorf DF Jr (1963) Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med 114:64–67

    Google Scholar 

  6. Bohle C, Sinn M, Werner E, Staib F (1986) Cryptococcus neoformans — Meningoencephalitis bei AIDS. Klin Wochenschr 64:165–172

    Google Scholar 

  7. Brandriss MW, Wolff SM, Moores R, Stohlmann F (1964) Anemia induced by amphotericin B. JAMA 189:663–666

    Google Scholar 

  8. Butler WT (1966) Pharmacology, toxicity, and therapeutic usefulness of amphotericin B. JAMA 195:127–131

    Google Scholar 

  9. Centers for Disease Control (1987) Revision on the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid Mortal Weekly Rep 36:1–15

    Google Scholar 

  10. Chandler FW (1985) Pathology of the mycosis in patients with the acquired immunodeficiency syndrome (AIDS). In: McGinnes MR (ed) Current topics in medical mycology, vol 1. Springer, New York Berlin Heidelberg, pp 1–23

    Google Scholar 

  11. Diamond RD, Bennett JE (1974) Prognostic factors in cryptococcal meningitis. Ann Intern Med 80:176–181

    Google Scholar 

  12. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, Shadomy S, Stamm AM, Diasio RB, Kaufman L, Song SJ, Blackwelder WC (1987) Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 317:334–341

    Google Scholar 

  13. Drutz DJ, Spickard A, Rogers DE, Koenig MG (1968) Treatment of disseminated mycotic infections. Am J Med 45:405–418

    Google Scholar 

  14. Edwards VE, Sutherland JM, Tyrer JH (1970) Cryptococcosis of the central nervous system. J Neurol Neurosurg Psych 33:415–425

    Google Scholar 

  15. Giberson TP, Kalyan-Raman K (1987) Cryptococcal meningitis: initial presentation of acquired immunodeficiency syndrome. Ann Emerg Med 16:114–116

    Google Scholar 

  16. Goodman JS, Kaufman L, Koenig MG (1971) Diagnosis of cryptococcal meningitis. N Engl J Med 285:434–436

    Google Scholar 

  17. Gordin FM, Simon GL, Wofsy CB, Mills J (1984) Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100:495–499

    Google Scholar 

  18. Grosse G, Niedobitek F, l'Age M, Staib F (1981) Chronische Lungenkryptokokkose. Dtsch Med Wochenschr 106:1035–1037

    Google Scholar 

  19. Heidemann HT, Brune KH (1987) Verhinderung der Amphotericin B — Nephrotoxizität durch parenteral verabreichtes Flucytosin. Therapiewoche 37:4158–4166

    Google Scholar 

  20. Heidemann HT, Gerkens JF, Spickard WA, Jackson EK, Branch RA (1983) Amphotericin B nephrotoxicity in humans decreased by salt repletion. Am J Med 75:476–481

    Google Scholar 

  21. Houk VN, Moser KM (1965) Pulmonary cryptococcosis. Ann Intern Med 63:583–596

    Google Scholar 

  22. Just G, Helm EB, Stille W (1986) Cryptococcus-neoformans-Infektion bei AIDS. Dtsch Med Wochenschr 111:1420–1421

    Google Scholar 

  23. Kaplan MH, Rosen PP, Armstrong D (1977) Cryptococcosis in a cancer hospital. Cancer 39:2265–2274

    Google Scholar 

  24. Kerkering TM, Duma RJ, Shodomy S (1981) The evolution of pulmonary cryptococcosis. Ann Intern Med 94:611–616

    Google Scholar 

  25. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, Gelman EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur H (1985) Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103:533–538

    Google Scholar 

  26. Liss HP, Rimland D (1981) Asymptomatic cryptococcal meningitis. Am Rev Respir Dis 88–89

  27. Medoff G, Kobayashi GS (1975) Amphotericin B. JAMA 232:619–620

    Google Scholar 

  28. Meyer R, Axelrod JL (1974) Fatal aplastic anemia resulting from flucytosine. JAMA 228:1573

    Google Scholar 

  29. Miller RP, Bates JH (1969) Amphotericin B toxicity. Ann Intern Med 71:1089–1095

    Google Scholar 

  30. Perfect JR, Durck DT, Gallis HA (1983) Cryptococcemia. Medicine (Baltimore) 62:98–109

    Google Scholar 

  31. Pohle HD, Eichenlaub D (1986) ZNS-Toxoplasmose und generalisierte Kryptokokkose bei AIDS. In: Helm EB, Stille W, Vanek E (eds) AIDS II. Zuckschwerdt, Munich, pp 136–142

    Google Scholar 

  32. Pohle HD, Eichenlaub D (1987) ZNS-Toxoplasmose bei AIDS-Patienten. AIDS-Forschung 3:122–135

    Google Scholar 

  33. Sabetta JR, Andriole VT (1985) Cryptococcal infection of the central nervous system. Med Clin North Am 69:333–344

    Google Scholar 

  34. Sarosi GA, Parker JD, Doto IL, Tosh FE (1969) Amphotericin B in cryptococcal meningitis. Ann Intern Med 71:1079–1087

    Google Scholar 

  35. Staib F (1986) Detection of Cryptococcus neoformans in biopsy specimens from the spleen and the liver of AIDS patients: Critical comments. Mykosen 29:551–555

    Google Scholar 

  36. Staib F (1987) Kryptokokkose bei AIDS aus mykologisch-diagnostischer und-epidemiologischer Sicht. AIDS-Forschung 2:363–382

    Google Scholar 

  37. Staib F, Rögler G, Prüfer-Krämer L, Seibold M, Eichenlaub D, Pohle HD (1986) Disseminierte Kryptokokkose bei zwei AIDS-Patienten. Dtsch Med Wochenschr 111:1061–1065

    Google Scholar 

  38. Staib F, Seibold M, Antweiler E, Fröhlich B, Heißenhuber M, Voigt R, Winger U, Pfau H, Krumhaar D, Neusetzer H (1986) Cryptococcus neoformans bei Patienten einer Berliner Lungenklinik — Ein Beitrag zur Diagnostik und Bekämpfung der Cr. neoformans-Mykose. Prax Klin Pneumol 40:86–93

    Google Scholar 

  39. Staib F, Seibold M, Antweiler E, Fröhlich B, Weber S, Blisse A (1987) The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of C. neoformans infections in AIDS patients. Zentralbl Bakt Hyg 266:167–177

    Google Scholar 

  40. Stockman L, Roberts GD (1982) Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J Clin Microbiol 16:965–967

    Google Scholar 

  41. Stockstill MT, Kauffman CA (1983) Comparison of cryptococcal and tuberculous meningitis. Arch Neurol 40:81–85

    Google Scholar 

  42. Tjia TL, Yoew YK, Tan CB (1985) Cryptococcal meningitis. J Neurol 48:853–858

    Google Scholar 

  43. Utz JP, Butler WT (1965) Cryptococcus-Meningitis. Dtsch Med Wochenschr 90:941–943

    Google Scholar 

  44. Utz JP, Garriques IL, Sande MA, Warner JF, Mandell GL, McGee RF, Duma RJ, Shadomy S (1975) Therapy of cryptococcosis with a combination of Flucytosin and Amphotericin B. J Infect Dis 132:368–373

    Google Scholar 

  45. Wegener HH, Staib F (1983) Tödliche Cryptococcose eines Vogelliebhabers. Ein kasuistischer Beitrag zur Pathologie, Diagnostik und Epidemiologie der Cryptococcose. Zentralbl Bakteriol Hyg 256:231–238

    Google Scholar 

  46. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 104:234–240

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weinke, T., Rögler, G., Sixt, C. et al. Cryptococcosis in AIDS patients: observations concerning CNS involvement. J Neurol 236, 38–42 (1989). https://doi.org/10.1007/BF00314216

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314216

Key words

Navigation